OSEBX1 945,09+0,00 %
EQNR349,90+0,00 %
DNB281,10+0,00 %
MOWI202,20+0,00 %
Brent$101,96+0,68 %
Gold$4 716,30+0,47 %
USD/NOK9,3028+0,03 %
EUR/NOK10,9336+0,07 %
SPX7 365,12+1,46 %
NDX28 599,17+2,08 %
MARKETS CLOSED · LAST TRADE Thu 03:20 UTC
KITS60

Kits Eyecare Ltd

Miscellaneous Specialty RetailersVerified
Score breakdown
Profitability+32Sentiment+30Missing signals-3
Quality breakdown
Key fields100Profile38Conclusion99AI synthesis40Observations23

Kits Eyecare Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating limited leverage and a strong equity base [doc:KITS.TO_ValuationSnapshot]. The company's liquidity position is robust, with a current ratio of 1.34 and cash and equivalents amounting to CAD 29.8 million, which provides a buffer against short-term obligations [doc:KITS.TO_ValuationSnapshot]. Free cash flow of CAD 5.35 million in the latest period supports operational flexibility and potential reinvestment [doc:KITS.TO_FinancialSnapshot]. Profitability metrics show a return on equity of 4.99% and a return on assets of 2.75%, which are below the median for the Miscellaneous Specialty Retailers industry. This suggests that the company is underperforming in terms of asset utilization and shareholder returns relative to its peers [doc:KITS.TO_ValuationSnapshot]. Gross profit of CAD 72.1 million represents 35.6% of revenue, but operating income of CAD 6.65 million indicates a relatively narrow margin, which may be sensitive to cost fluctuations [doc:KITS.TO_FinancialSnapshot]. The company's revenue is concentrated in a single business segment focused on eyewear and contact lens sales, with no disclosed geographic diversification beyond Canada. This lack of segment or geographic diversification increases exposure to regional economic shifts and consumer demand volatility [doc:KITS.TO_Description]. Looking ahead, Kits Eyecare Ltd is projected to grow revenue by 12.5% in the current fiscal year and 15.0% in the next, driven by expansion of its online vision tools and designer eyewear partnerships [doc:KITS.TO_Outlook]. However, the company's operating income growth is expected to lag at 6.0% and 7.5% respectively, reflecting margin pressures from competitive pricing and rising logistics costs [doc:KITS.TO_Outlook]. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce refinancing risk, while the absence of dilutive events in the near term supports stable ownership structure [doc:KITS.TO_RiskAssessment]. However, the company's reliance on a single product category and geographic market introduces concentration risk that could affect long-term stability [doc:KITS.TO_FinancialSnapshot]. Recent events include the launch of the KITS x Vasuma designer eyewear collection and the expansion of its Autoship subscription program for contact lenses. These initiatives aim to enhance customer retention and average order value [doc:KITS.TO_Description]. No material regulatory or legal risks were disclosed in the latest filings, and the company's capital expenditure of CAD 136,000 in the latest period reflects a minimal investment in physical infrastructure [doc:KITS.TO_FinancialSnapshot].

Profile
CompanyKits Eyecare Ltd
TickerKITS.TO
SectorConsumer Cyclicals
BusinessRetailers
Industry groupRetailers
IndustryMiscellaneous Specialty Retailers
AI analysis

Business. Kits Eyecare Ltd is a Canada-based provider of vertically integrated and digitally native eyecare platforms, generating revenue through the sale of eyewear products and contact lenses to consumers [doc:KITS.TO_Description].

Classification. Kits Eyecare Ltd is classified under the Consumer Cyclicals economic sector, Retailers business sector, and Miscellaneous Specialty Retailers industry with a confidence level of 0.92 [doc:KITS.TO_Classification].

Kits Eyecare Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.25, indicating limited leverage and a strong equity base [doc:KITS.TO_ValuationSnapshot]. The company's liquidity position is robust, with a current ratio of 1.34 and cash and equivalents amounting to CAD 29.8 million, which provides a buffer against short-term obligations [doc:KITS.TO_ValuationSnapshot]. Free cash flow of CAD 5.35 million in the latest period supports operational flexibility and potential reinvestment [doc:KITS.TO_FinancialSnapshot]. Profitability metrics show a return on equity of 4.99% and a return on assets of 2.75%, which are below the median for the Miscellaneous Specialty Retailers industry. This suggests that the company is underperforming in terms of asset utilization and shareholder returns relative to its peers [doc:KITS.TO_ValuationSnapshot]. Gross profit of CAD 72.1 million represents 35.6% of revenue, but operating income of CAD 6.65 million indicates a relatively narrow margin, which may be sensitive to cost fluctuations [doc:KITS.TO_FinancialSnapshot]. The company's revenue is concentrated in a single business segment focused on eyewear and contact lens sales, with no disclosed geographic diversification beyond Canada. This lack of segment or geographic diversification increases exposure to regional economic shifts and consumer demand volatility [doc:KITS.TO_Description]. Looking ahead, Kits Eyecare Ltd is projected to grow revenue by 12.5% in the current fiscal year and 15.0% in the next, driven by expansion of its online vision tools and designer eyewear partnerships [doc:KITS.TO_Outlook]. However, the company's operating income growth is expected to lag at 6.0% and 7.5% respectively, reflecting margin pressures from competitive pricing and rising logistics costs [doc:KITS.TO_Outlook]. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt load and strong cash position reduce refinancing risk, while the absence of dilutive events in the near term supports stable ownership structure [doc:KITS.TO_RiskAssessment]. However, the company's reliance on a single product category and geographic market introduces concentration risk that could affect long-term stability [doc:KITS.TO_FinancialSnapshot]. Recent events include the launch of the KITS x Vasuma designer eyewear collection and the expansion of its Autoship subscription program for contact lenses. These initiatives aim to enhance customer retention and average order value [doc:KITS.TO_Description]. No material regulatory or legal risks were disclosed in the latest filings, and the company's capital expenditure of CAD 136,000 in the latest period reflects a minimal investment in physical infrastructure [doc:KITS.TO_FinancialSnapshot].
Key takeaways
  • Kits Eyecare Ltd maintains a conservative capital structure with strong liquidity and low leverage.
  • Profitability metrics lag behind industry medians, indicating underperformance in asset utilization and returns.
  • Revenue is concentrated in a single business segment and geographic market, increasing exposure to regional demand shifts.
  • Analysts project mid-teens revenue growth, but operating income growth is expected to remain modest.
  • The company faces low liquidity and dilution risk, but its business model is exposed to concentration risk.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCAD
Revenue$202.5M
Gross profit$72.1M
Operating income$6.6M
Net income$3.1M
R&D
SG&A
D&A
SBC
Operating cash flow$11.5M
CapEx-$136.0k
Free cash flow$5.4M
Total assets$113.0M
Total liabilities$50.6M
Total equity$62.3M
Cash & equivalents$29.8M
Long-term debt$15.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$62.3M
Net cash$14.0M
Current ratio1.3
Debt/Equity0.2
ROA2.8%
ROE5.0%
Cash conversion3.7%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Retailers · cohort 2 companies
MetricKITSActivity
Op margin3.3%20.7% medp25 18.7% · p75 22.8%bottom quartile
Net margin1.5%15.6% medp25 13.4% · p75 17.7%bottom quartile
Gross margin35.6%31.0% medp25 19.6% · p75 40.5%above median
R&D / revenue0.4% medp25 0.4% · p75 0.4%
CapEx / revenue-0.1%4.6% medp25 3.2% · p75 5.9%bottom quartile
Debt / equity25.0%39.3% medp25 19.7% · p75 97.3%below median
Observations
IR observations
Mean price target24.29 CAD
Median price target25.00 CAD
High price target27.00 CAD
Low price target20.00 CAD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count7.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.26 CAD
Last actual EPS0.09 CAD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 10:59 UTC#302b09f5
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 11:01 UTCJob: bcbb908d